Cargando…
The impact of COVID-19 on the cell and gene therapies industry: Disruptions, opportunities, and future prospects
Coronavirus 2019 (COVID-19) has caused significant disruption to the cell and gene therapy (CGT) industry, which has historically faced substantial complexities in supply of materials, and manufacturing and logistics processes. As decision-makers shifted their priorities to COVID-19-related issues,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057929/ https://www.ncbi.nlm.nih.gov/pubmed/33892148 http://dx.doi.org/10.1016/j.drudis.2021.04.020 |